New pill aims to tame painful lupus skin flares in major trial
NCT ID NCT07332481
Summary
This study aims to see if a new oral medication called enpatoran is effective and safe for treating active skin rashes caused by lupus. It will involve about 202 adults with cutaneous lupus, who may or may not also have systemic lupus. Participants will take either the study drug or a placebo pill for 24 weeks, in addition to their standard lupus care, to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Billerica, Massachusetts, 01821, United States
Conditions
Explore the condition pages connected to this study.